Drug abuse often leads to incidences of violence, child abuse, drinking under influence, and many other offences. Drugs of abuse testing devices are used by authorities and government agents to reduce the probability of such cases. Students and civilians are seen as the most frequent users of such drugs. According to the European Monitoring Center for Drugs and Drug Addiction, nearly 30,000 people die annually on European roads owing to consumption of alcohol, medicinal or illicit drugs, and psychoactive substances. As a result, stringent government policies have been outlined in order to dissuade drug abuse.
In-Depth research report on Drugs of Abuse Testing Devices Market:
Launch of New Testing Kits
Test samples include breath, saliva, hair, sweat, blood, and urine and drug testing products are based primarily on the type of sample to be tested. Alere Inc., a manufacturer of drug testing kits, has launched a portable system for testing the presence of drugs. It relies on saliva to provide information to the user within minutes. It can be ideally used by authorities in conducting roadside checks. It can be used to prevent traffic accidents as well as ensure safety of civilians.
Intelligent Printing, a U.K. firm, has introduced a portable system capable of screening potential users. It can reportedly show traces of four main drug groups in an individual by using fingerprints. This system can be used in deaddiction centers and rehabilitation programs.
Market Insights
The drugs of abuse testing devices market in Europe, Middle East, and Africa (EMEA) is projected to expand at a significant CAGR from 2012 to 2022 (forecast period), according to a report on Radiant Insights, Inc. Alarming incidence of drug abuse among students and employees in these regions can be the major driver of this market. Recent legalization of marijuana has also led to reorganization of drug testing policies by various countries.
The Middle East market is introducing new testing policies for aviation employees in United Arab Emirates (UAE) and Saudi Arabia to dissuade drug use or aircraft accidents. This is expected to benefit the entire EMEA market.
Key market players include F. Hoffmann-La Roche AG; Alere Inc.; Thermo Fisher Scientific; and Drägerwerk AG. Development of transdermal tests by these players can act as a game changer in future.
To get free request sample at :
No comments:
Post a Comment